Antitumor Effects of Interferon

Reference

• Strander H. Interferon treatment of human neoplasia. Adv Cancer Res 1986; 46: 1
   PubMedGoogle Scholar
• Gresser I, Coppey J, Falcoff E, Fontaine D. Interferon and murine leukemia. I. Inhibitory effect of interferon preparations on the development of Friend leukemia in mice. Proc Soc Exp Biol Med 1967; 124: 84
   PubMedGoogle Scholar
• Gresser I, Coppey J, Fontaine-Brouty-Boye D, Falcoff R, Falcoff E, Zajdela F. Interferon and murine leukemia. III. Efficacy of interferon preparations administered after inoculation of Friend virus. Nature 1967; 215: 174
   PubMedGoogle Scholar
• Gresser I, Coppey J, Fontaine-Brouty-Boye D, et al. The effect of interferon preparations on Friend leukemia in mice. Ciba Symposium on Interferon 1967; 240
   Google Scholar
• Gresser I, Berman L, de The G, Brouty-Boye D, Coppey J, Falcoff E. Interferon and murine leukemia. V. Effect of interferon preparations on the evolution of Rauscher disease in mice. J Natl Cancer Inst 1968; 41: 505
   PubMedGoogle Scholar
• Finter NB. A rich source of mouse interferon. Nature 1964; 204: 1114
   PubMedGoogle Scholar
• Gresser I, Coppey J, Bourali C. Interferon and murine leukemia. VI. The effect of interferon preparations on the lymphoid leukemia of AKR mice. J Natl Cancer Inst 1969; 43: 1083
   PubMedGoogle Scholar
• Strander H, Cantell K, Ingimarsson S, Jakobsson P A, Nilsonne U, Söderberg G. Interferon treatment of osteogenic sarcoma—a clinical trial. In: Modulation of host immune resistance in the prevention or treatment of induced neoplasias. Fogarty Intern. Center Proc, Washington, DC. US Government Printing Office 1977; 28: 377
   Google Scholar
• Blomgren H, Cantell K, Johansson B, Lagergran C, Ring-Borg U, Strander H. Interferon therapy in Hodgkin's disease—a case report. Acta Med Scand 1976; 199: 527
   PubMedGoogle Scholar
• Mellstedt H, Björkholm M, Johansson B, Ahre A, Holm G, Strander H. Interferon therapy in myelomatosis. Lancet 1979; 1: 245
   PubMed Web of Science ®Google Scholar
• Cantell K. Why is interferon not in clinical use today?. Interferon, I Gresser. Academic Press, London 1979; 1: 1
   Google Scholar
• Lampson G P, Tyrell A A, Nemes M M, Hilleman MR. Purification and characterization of chick embryo interferon. Proc Soc Exp Biol Med 1963; 112: 468
   PubMed Web of Science ®Google Scholar
• Gresser I, Bourali C, Levy J P, Fontaine-Brouty-Boye D, Thomas MT. Increaed survival in mice inoculated with tumor cells and treated with interferon preparations. Proc Natl Acad Sci USA 1969; 63: 51
   PubMed Web of Science ®Google Scholar
• Gresser I, Bourali C. Exogenous interferon and inducers of interferon in the treatment of Balb/c mice inoculated with RC19 tumor cells. Nature 1969; 223: 844
   PubMedGoogle Scholar
• Gresser I, Bourali C, Chouroulinkov I, Fontaine-Brouty-Boye D, Thomas MT. Treatment of neoplasia in mice with interferon preparations. Second Conference on Antiviral Substances. New York Acad Sci 1970; 173: 694
   Web of Science ®Google Scholar
• Gresser I, Bourali C. Antitumor effects of interferon preparations in mice. J Natl Cancer Inst 1970; 45: 365
   PubMed Web of Science ®Google Scholar
• Gresser I, De Maeyer-Guignard J, Tovey M G, de Maeyer E. Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci USA 1979; 76: 5308
   PubMed Web of Science ®Google Scholar
• Gresser I, Bourali C. Inhibition by interferon preparations of the growth of a solid malignant tumour and the development of pulmonary metastases in mice. Nature New Biology 1972; 236: 78
   PubMedGoogle Scholar
• Burke D C, Isaacs A. Some factors affecting the production of interferon. Br J Exp Pathol 1958; 39: 452
   PubMedGoogle Scholar
• Stewart WE, II, Gosser L B, Lockart Z, Jr. Priming: a non antiviral function of interferon. J Virol 1971; 7: 792
   PubMedGoogle Scholar
• Gresser I. Metamorphosis of human amnion cells induced by preparations of interferon. Proc Natl Acad Sci USA 1961; 47: 1817
   PubMed Web of Science ®Google Scholar
• Paucker K, Cantell K, Henle W. Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology 1962; 17: 324
   PubMed Web of Science ®Google Scholar
• Baron S, Merigan T C, McKerlie ML. Effect of crude and purified interferons on the growth of uninfected cells in culture. Proc Soc Exp Biol Med 1966; 121: 50
   PubMedGoogle Scholar
• Levy H B, Merigan TC. Interferon and uninfected cells. Proc Soc Exp Biol Med 1966; 121: 53
   PubMed Web of Science ®Google Scholar
• Gresser I, Brouty-Boye D, Thomas M T, Macieira-Coelho A. Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations. Proc Natl Acad Sci USA 1970; 66: 1052
   PubMed Web of Science ®Google Scholar
• Gresser I, Brouty-Boye D, Thomas M T, Macieira-Coelho A. Interferon and cell division. II. Influence of various experimental conditions on the inhibition of L 1210 cell multiplication in vitro by interferon preparations. J Natl Cancer Inst 1970; 45: 1145
   PubMedGoogle Scholar
• Macieira-Coelho A, Brouty-Boye D, Thomas M T, Gresser I. Interferon and cell division. III. Effect of interferon on the division cycle of L 1210 cells in vitro. J Cell Biol 1971; 48: 415
   PubMedGoogle Scholar
• Gresser I, Thomas M T, Brouty-Boye D, Macieira-Coelho A. Interferon and cell division. IV. Effect of interferon treatment of L 1210 cells in vitro on tumor and colony formation. Nature New Biology 1971; 231: 20
   PubMedGoogle Scholar
• Gresser I, Thomas M T, Brouty-Boye D, Macieira-Coelho A. Interferon and cell division. V. Titration of the anti-cellular action of interferon preparations. Proc Soc Exp Biol Med 1971; 137: 1258
   PubMedGoogle Scholar
• Lindahl-Magnusson P, Leary P, Gresser I. Interferon and cell division. VI. Inhibitory effect of interferon on the multiplication of mouse embryo and mouse kidney cells in primary cultures. Proc Soc Exp Biol Med 1971; 138: 1044
   PubMedGoogle Scholar
• Lindahl-Magnusson P, Leary P, Gresser I. Interferon inhibits DNA-synthesis induced in mouse lymphocytes suspensions by phytohemagglutinin or by allogeneic cells. Nature New Biology 1972; 273: 120
   Google Scholar
• Gresser I, Bandu M T, Tovey M G, Bodo G, Paucker K, Stewart II W. Interferon and cell division. VII. Inhibitory effect of purified interferon preparations on the multiplication of leukemia L 1210 cells. Proc Soc Exp Biol Med 1972; 142: 7
   Google Scholar
• Brouty-Boye D, Macieira-Coelho A, Fisrman M, Gresser I. Interferon and cell division. VIII. Effect of interferon on macromolecular synthesis in L 1210 cells in vitro. Int J Cancer 1973; 12: 250
   PubMedGoogle Scholar
• McNeil T A, Gresser I. Inhibition of haemopoietic colony growth by interferon preparation from different sources. Nature New Biology 1973; 244: 173
   PubMedGoogle Scholar
• Gresser I, Bandu M T, Brouty-Boye D. Interferon and cell division. IX. Interferon-resistant L 1210 cells: characteristics and origin. J Natl Cancer Inst 1974; 52: 553
   PubMedGoogle Scholar
• Brouty-Boye D. Inhibitory effects of interferons on cell multiplication. Lymphokine reports. A forum for non-antibody lymphokine products. New York: Academic Press 1980; 1: 99
   Google Scholar
• Cerottini J C, Brunner K T, Lindahl P, Gresser I. Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogeneic spleen cells and syngeneic bone marrow cells. Nature New Biology 1973; 242: 152
   PubMedGoogle Scholar
• Frayssinet C, Gresser I, Tovey M, Lindahl P. Inhibitory effect of potent interferon preparations on the regeneration of mouse liver after partial hepatectomy. Nature 1973; 245: 146
   PubMedGoogle Scholar
• Gresser I, Tovey M G, Maury C, Chouroulinkov I. Lethality of interferon preparations for new-borne mice. Nature 1975; 258: 76
   PubMedGoogle Scholar
• Moss J, Woodrow D, Sloper J C, Riviere Y, Guillon J C, Gresser I. Interferon as a cause of endoplasmic reticulum abnormalities within hepatocytes in newborn mice. Br J Exp Pathol 1982; 63: 43
   PubMedGoogle Scholar
• Gresser I, Morel-Maroger L, Maury C, Tovey M G, Pontillon F. Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature 1976; 263: 420
   PubMed Web of Science ®Google Scholar
• Woodrow D, Ronco P, Riviere Y, et al. Severity of glomerulonephritis induced in different strains of suckling mice by infection with lymphocytic choriomeningitis virus: correlation with amounts of endogenous interferon and circulating immune complexes. J Pathol 1982; 138: 325
   PubMedGoogle Scholar
• Woodrow D, Moss J, Gresser I. Interferon induces pulmonary cysts in A2G mice. Proc Natl Acad Sci USA 1984; 81: 7937
   PubMedGoogle Scholar
• Gresser I. Interferon and the immune system. Progress in Immunology IV, M Fougereau, J Dausset. Academic Press, London 1980; 710
   Google Scholar
• de Maeyer E, de Maeyer J. Immuno-modulating properties of interferons. Philos Trans R Soc Lond 1982; 299: 77
   PubMedGoogle Scholar
• Lindahl P, Leary P, Gresser I. Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci USA 1973; 70: 2785
   PubMedGoogle Scholar
• Lindahl P, Leary P, Gresser I. Enhancement by interferon of the expression of histocompatibility antigens of mouse lymphoid cells in vitro. Eur J Immunol 1974; 4: 779
   Google Scholar
• Lindahl P, Gresser I, Leary P, Tovey M. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci USA 1976; 73: 1284
   PubMedGoogle Scholar
• Vignaux F, Gresser I. Differential effects of interferon on the expression of H-2K, H-2D and la antigens on mouse lymphocytes. J Immunol 1977; 118: 721
   PubMedGoogle Scholar
• Gresser I, Guy-Grand D, Maury C, Maunoury MT. Interferon induces peripheral lymphadenopathy in mice. J Immunol 1981; 127: 1569
   PubMedGoogle Scholar
• Crane JL, Jr., Glasgow L A, Kern E R, Youngner JS. Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon. J Natl Cancer Inst 1978; 61: 871
   PubMedGoogle Scholar
• Balkwill F R, Goldstein L, Stebbing N. Differential action of six human interferons against two human carcinomas growing in nude mice. Int J Cancer 1985; 35: 613
   PubMedGoogle Scholar
• Brosjö O, Bauer H CF, Broström L A, et al. Influence of human α-interferon on four human osteosarcoma xenografts in nude mice. Cancer Res 1985; 45: 5598
   PubMed Web of Science ®Google Scholar
• Lee S H, Chiu H, Rinderknecht E, Sabo W, Stebbing N. Importance of treatment regimen of interferon as an antitumor agent. Cancer Res 1983; 43: 4172
   PubMed Web of Science ®Google Scholar
• Gresser I, Belardelli F, Maury C, Tovey M G, Maunoury MT. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. IV. Definition of optimal treatment regimens. Int J Cancer 1986; 38: 251
   PubMedGoogle Scholar
• Belardelli F, Gresser I, Maury C, Maunoury MT. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I. Int J Cancer 1982; 30: 813
   PubMedGoogle Scholar
• Affabris E, Jemma C, Rossi GB. Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain. Virology 1982; 120: 441
   PubMedGoogle Scholar
• Gresser I, Maury C, Brouty-Boye D. On the mechanism of the antitumour effect of interferon in mice. Nature 1972; 239: 167
   PubMed Web of Science ®Google Scholar
• Locardi C, Belardelli F, Federico M, Romeo G, Affabris E, Gresser I. Effect of mouse interferon α/β on the expression of H-2 (class I) antigens and on the levels of 2′-5′ oligoadeny-late synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice. J Biol Reg Homeost Agents 1987; 1: 189
   PubMedGoogle Scholar
• Gresser I, Bourali-Maury C. The antitumor effect of interferon in lymphocyte and macrophage depressed mice. Proc Soc Exp Biol Med 1973; 144: 896
   PubMedGoogle Scholar
• Belardelli F, Gresser I, Maury C, Maunoury MT. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms. Int J Cancer 1982; 30: 821
   PubMedGoogle Scholar
• Belardelli F, Gresser I, Maury C, Duvillard P, Prade M, Maunoury MT. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously. Int J Cancer 1983; 31: 649
   PubMedGoogle Scholar
• Gresser I, Belardelli F, Tavernier J et al. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor. Int J Cancer 1986; 38: 771
   PubMedGoogle Scholar
• Podo F, Carpinelli G, Di Vito M et al. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia-cell tumors and fibrosarcoma in mice. Cancer Res 1987; 47: 6481
   PubMedGoogle Scholar
• Gresser I, Maury C, Belardelli F. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. VI. Adjuvant therapy after surgery in the inhibition of liver and spleen metastases. Int J Cancer 1987; 39: 789
   PubMedGoogle Scholar
• Gresser I, Maury C, Woodrow D et al. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells. Int J Cancer 1988; 41: 135
   PubMedGoogle Scholar
• Gresser I, Maury C, Belardelli F, Maunoury M T, Machover D. Mouse interferon α/β is more effective than single agent chemotherapy in increasing the survival time of mice after intravenous inoculation of Friend erythroleukemia cells. J Natl Cancer Inst 1988; 80: 126
   PubMedGoogle Scholar